NOVOCAIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Novocain, and when can generic versions of Novocain launch?
Novocain is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in NOVOCAIN is procaine hydrochloride. There are seventeen drug master file entries for this compound. Additional details are available on the procaine hydrochloride profile page.
Summary for NOVOCAIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Patent Applications: | 4,260 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NOVOCAIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NOVOCAIN
US Patents and Regulatory Information for NOVOCAIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 085362-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 085362-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 086797-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |